Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of STK39 mRNA | decreases expression | 19933214
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of STK39 mRNA | affects expression | 17562736
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone results in increased expression of STK39 mRNA | increases expression | 17131305
|
D013196 |
Dihydrotestosterone |
PD 98059 inhibits the reaction [Dihydrotestosterone results in increased expression of STK39 mRNA] | decreases reaction|increases expression | 17131305
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of STK39 mRNA | affects expression | 16483693
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of STK39 mRNA | decreases expression | 20064835 20106945
|
D003520 |
Cyclophosphamide |
[Doxorubicin co-treated with Cyclophosphamide] affects the expression of STK39 mRNA | affects cotreatment|affects expression | 16322899
|
C004742 |
daidzein |
daidzein results in decreased expression of STK39 mRNA | decreases expression | 16865672
|
D016190 |
Carboplatin |
Carboplatin results in decreased expression of STK39 mRNA | decreases expression | 18172885
|
D002945 |
Cisplatin |
Cisplatin results in decreased expression of STK39 mRNA | decreases expression | 18172885
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of STK39 mRNA | increases expression | 16002434
|
D004317 |
Doxorubicin |
[Doxorubicin co-treated with Cyclophosphamide] affects the expression of STK39 mRNA | affects cotreatment|affects expression | 16322899
|
C007610 |
equol |
equol results in decreased expression of STK39 mRNA | decreases expression | 16865672
|
D004958 |
Estradiol |
Estradiol results in increased expression of STK39 mRNA | increases expression | 17131305
|
D004958 |
Estradiol |
fulvestrant inhibits the reaction [Estradiol results in increased expression of STK39 mRNA] | decreases reaction|increases expression | 17131305
|
D004958 |
Estradiol |
PD 98059 inhibits the reaction [Estradiol results in increased expression of STK39 mRNA] | decreases reaction|increases expression | 17131305
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of STK39 mRNA | decreases expression | 18035473
|
C070081 |
fulvestrant |
fulvestrant inhibits the reaction [Estradiol results in increased expression of STK39 mRNA] | decreases reaction|increases expression | 17131305
|
D019833 |
Genistein |
Genistein results in decreased expression of STK39 mRNA | decreases expression | 16865672 15378649
|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in decreased expression of STK39 mRNA | decreases expression | 12634122
|
D015741 |
Metribolone |
Metribolone results in increased expression of STK39 mRNA | increases expression | 17131305
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [Dihydrotestosterone results in increased expression of STK39 mRNA] | decreases reaction|increases expression | 17131305
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [Estradiol results in increased expression of STK39 mRNA] | decreases reaction|increases expression | 17131305
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of STK39 mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of STK39 mRNA | increases expression | 18301758
|
C052785 |
rebamipide |
rebamipide results in increased expression of STK39 mRNA | increases expression | 18299717
|
C010327 |
salinomycin |
salinomycin results in decreased expression of STK39 mRNA | decreases expression | 19682730
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of STK39 mRNA | decreases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of STK39 mRNA | decreases expression | 19933214
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of STK39 mRNA | increases expression | 20159946
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.70 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.41 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
3.82 | 15814532 17670903 12690470 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.97 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
16.64 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
16.64 | 11798837 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
daidzein |
16.64 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
16.64 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
16.64 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
16.64 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.57 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.39 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.39 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.40 | 21441931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.81 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.69 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.92 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.45 | 15014928 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.70 | 11514358 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 18348195 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.43 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.31 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.31 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.64 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.67 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
11.55 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
11.55 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.68 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
8.16 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
8.16 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
8.16 | 18382427 19526202 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
8.16 | 15093573 18234424 15136595 11325840 17020986 16978400 12006526 17388661 18323546 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
8.16 | 16826403 15939500 17369602 18628466 19526202 16322301 17983394 18695136 18234424 18382427 15668708 16935488 11325840 16595493 15993339 15994142 16115903 15567936 17426702 16264153 15692762 15634643 16096432 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
equol |
8.16 | 16898868 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
8.16 | 12948864 19861407 17018787 14630087 17289903 17261762 18497071 16675129 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
8.16 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
8.16 | 16541309 17200150 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
salinomycin |
8.16 | 19682730 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
8.16 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.31 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.66 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.68 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
11.08 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
11.08 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
11.08 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
11.08 | 16023760 18059187 16234567 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
11.08 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
11.08 | 16924424 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.74 | 16152834 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Carboplatin |
5.98 | 16685392 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
5.98 | 12023789 16685392 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
6.63 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.63 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
10.47 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
10.47 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
10.47 | 6189445 18337622 17066447 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
10.47 | 6189445 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.28 | 18850075 16120746 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.43 | 15811867 16455267 17351982 17382496 16269455 16952015 15792986 17308081 17131338 16278810 16651473 16242529 18627295 17519947 15505089 17974986 17329180 17007740 16731534 16612575 16109756 17924179 15476868 17928571 16364871 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.89 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
daidzein |
7.45 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
7.45 | 16332659 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.49 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.77 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
6.77 | 2727394 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.03 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.71 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.04 | 8697196 12621046 16354765 15340226 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
2.26 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
2.73 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.73 | 18802399 18259882 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.93 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 15322242 20055451 10048152 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.83 | 17979934 16413132 10700343 10498854 18483878 16614059 12161096 12388444 11948286 16989017 18433785 18372110 15643279 15276878 18295254 18093676 12913760 18710439 16651033 17010015 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.36 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
3.94 | 11751995 15331540 10990075 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.17 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
daidzein |
7.05 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
7.05 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
7.05 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.28 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
5.91 | 15968718 14550746 10774834 10915739 2444490 11739529 19923254 11287661 11421492 19416960 16485898 11461765 17562736 14986274 12392966 14725611 11834606 11529661 16109766 19739265 12958197 16781746 16393943 17906064 15619225 12705907 16227642 12540782 19370779 18071297 18713872 11743745 12594235 10663392 12153990 16177239 19164858 16081117 17522070 19085960 19420014 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
5.91 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.91 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.95 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
13.13 | 15033597 12649298 12231392 19839026 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
13.13 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
13.13 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.08 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.08 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.75 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
3.79 | 15138306 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.44 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
daidzein |
17.05 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
17.05 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
17.05 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
17.05 | 11473722 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.89 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.01 | 18037988 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.07 | 11006010 |
MESH:D007172 |
Erectile Dysfunction |
|
daidzein |
4.87 | 14972507 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.48 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
4.48 | 16481741 17638652 16785472 15464296 15173087 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.90 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
2.63 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.31 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.44 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.80 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.52 | 16983495 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
7.01 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
7.01 | 16598420 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.36 | 11389073 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.44 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.88 | 16376943 11014644 15172196 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
7.70 | 15464296 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.70 | 15692506 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
4.17 | 19898482 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.29 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.18 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.18 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.38 | 16707910 16495754 18674790 14766674 17888722 16244372 16144979 18006777 16244371 17875725 12587719 16879835 16330681 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.74 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.74 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.76 | 15692506 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.14 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.20 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.38 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.76 | 19772884 18467677 16221962 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.76 | 16120746 12621046 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.88 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
11.68 | 16200630 16170182 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
11.68 | 17606976 16135485 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
11.68 | 18501091 17606976 15147373 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.60 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.89 | 15340226 16959395 18606429 8697196 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.58 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.05 | 20558911 |
MESH:D006973 |
Hypertension |
|
daidzein |
5.33 | 17169123 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.33 | 18670907 18850075 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.18 | 16076520 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
7.00 | 7193160 16517039 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
7.00 | 11514358 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
4.74 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.74 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.87 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.87 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
rebamipide |
5.03 | 11686837 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.20 | 16580747 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.99 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
13.76 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
13.76 | 12649298 15190930 19839026 18289764 12231392 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
13.76 | 15699352 16775033 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
13.76 | 15618244 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.01 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
2.86 | 15610895 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.64 | 11231351 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
6.43 | 10602166 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.43 | 17468513 18980019 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.01 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.43 | 18172266 17008537 18587576 17658394 17296974 17802794 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
PD 98059 |
5.08 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
3.98 | 10373061 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.81 | 11830472 10052129 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
6.53 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.53 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
6.53 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.53 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.53 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.59 | 19784758 12587719 12969438 16611625 19460945 16610002 19014921 11587558 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.10 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
6.98 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
6.98 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
6.98 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
5.60 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.60 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.72 | 17053015 18816296 6695378 18569708 20464547 20135361 20869020 18520028 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
4.72 | 6189445 17225452 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
4.72 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.72 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
7.52 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.52 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.45 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
8.57 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
8.57 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.42 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
13.55 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
13.55 | 17203775 11807958 11408345 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
13.55 | 12929590 14578162 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
salinomycin |
13.55 | 19682730 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.33 | 19453300 |
MESH:D008545 |
Melanoma |
|
Carboplatin |
5.25 | 16225601 16342250 11712820 12040289 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
5.25 | 16432458 17761969 15577323 16248763 18505091 11135225 16809738 12883367 18176117 18332650 12393984 12374674 17023156 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
5.25 | 16827129 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
4.62 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
10.33 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
10.33 | 16388313 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
6.26 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.26 | 17638057 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
5.74 | 17671175 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.36 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.07 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.64 | 17415656 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.36 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
9.12 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
9.12 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
9.12 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.90 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
13.50 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
13.50 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
13.50 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
2.89 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
14.98 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Carboplatin |
14.98 | 18854779 17925555 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
14.98 | 16773208 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
14.98 | 18854779 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
14.98 | 17405874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.58 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.34 | 15464296 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.62 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.87 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
15.51 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
15.51 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.51 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
11.11 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
11.11 | 15176712 8761367 16115947 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
11.11 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.75 | 18514411 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Carboplatin |
18.35 | 12837982 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
18.35 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
18.35 | 8761367 12837982 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.18 | 8291058 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.78 | 20558911 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.56 | 16517039 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.16 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
3.94 | 16169203 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.99 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
7.69 | 15464296 19769630 17225452 6897625 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.69 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
7.69 | 19005980 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.44 | 16870215 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
6.44 | 12161096 18093676 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
5.55 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
5.55 | 11332152 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.10 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
4.16 | 15464296 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.01 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
13.43 | 17638057 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
13.43 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.41 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.72 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.04 | 11222880 11118676 11399792 11896295 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.63 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.75 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.08 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.08 | 16644109 18247401 16289102 15754350 12479363 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.08 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.08 | 16729912 15749863 18437689 15897917 16888761 16868541 |
MESH:D011471 |
Prostatic Neoplasms |
|
equol |
2.08 | 16898868 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.08 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.08 | 15256057 16925846 15378649 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.23 | 16636934 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
9.88 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
9.88 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.31 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.69 | 18990726 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.86 | 16767912 17710206 17203757 18313854 15675481 15625365 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
9.96 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
9.96 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.64 | 17846226 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.68 | 16636934 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.02 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
9.02 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.02 | 16192470 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
5.19 | 15464296 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.42 | 16767912 15625365 17203757 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.36 | 16517039 |
MESH:D013272 |
Stomach Diseases |
|
rebamipide |
5.12 | 16184426 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.51 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
3.51 | 17522103 18396642 15958060 |
MESH:D013274 |
Stomach Neoplasms |
|
rebamipide |
3.51 | 15993841 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Carboplatin |
11.97 | 12837982 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
11.97 | 12837982 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.49 | 15464296 17225452 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.75 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.26 | 16010429 17909728 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.53 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
11.51 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
11.51 | 12973940 17225452 15464296 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
11.51 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
11.51 | 17653716 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.83 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
4.07 | 16803524 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.46 | 15577323 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.44 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.07 | 17334414 16364871 17678736 17638931 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.57 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.10 | 15886252 |